Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-014775
Filing Date
2017-04-05
Accepted
2017-04-05 12:18:51
Documents
1
Period of Report
2017-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 13227
  Complete submission text file 0001140361-17-014775.txt   14599
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address
McCarthy Sean A. (Reporting) CIK: 0001654058 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 17741741